CN102149376B - 症状性心力衰竭的长期治疗 - Google Patents
症状性心力衰竭的长期治疗 Download PDFInfo
- Publication number
- CN102149376B CN102149376B CN2009801356010A CN200980135601A CN102149376B CN 102149376 B CN102149376 B CN 102149376B CN 2009801356010 A CN2009801356010 A CN 2009801356010A CN 200980135601 A CN200980135601 A CN 200980135601A CN 102149376 B CN102149376 B CN 102149376B
- Authority
- CN
- China
- Prior art keywords
- 3pufa
- weight
- fatty acid
- purposes
- heart failure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Magnetic Heads (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
Description
Claims (11)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08161994 | 2008-08-07 | ||
EP08161994.2 | 2008-08-07 | ||
PCT/EP2009/005347 WO2010015335A1 (en) | 2008-08-07 | 2009-07-23 | Long-term treatment of symptomatic heart failure |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102149376A CN102149376A (zh) | 2011-08-10 |
CN102149376B true CN102149376B (zh) | 2013-12-25 |
Family
ID=40101155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009801356010A Active CN102149376B (zh) | 2008-08-07 | 2009-07-23 | 症状性心力衰竭的长期治疗 |
Country Status (21)
Country | Link |
---|---|
US (1) | US8592439B2 (zh) |
EP (1) | EP2323647B1 (zh) |
JP (1) | JP5563573B2 (zh) |
KR (1) | KR20110058775A (zh) |
CN (1) | CN102149376B (zh) |
AU (1) | AU2009278317B2 (zh) |
BR (1) | BRPI0917403A2 (zh) |
CA (1) | CA2732071C (zh) |
CY (1) | CY1115785T1 (zh) |
DK (1) | DK2323647T3 (zh) |
EA (1) | EA020237B1 (zh) |
ES (1) | ES2524596T3 (zh) |
HK (1) | HK1160790A1 (zh) |
HR (1) | HRP20141149T1 (zh) |
MX (1) | MX2011001419A (zh) |
PL (1) | PL2323647T3 (zh) |
PT (1) | PT2323647E (zh) |
RS (1) | RS53694B1 (zh) |
SI (1) | SI2323647T1 (zh) |
SM (1) | SMT201500019B (zh) |
WO (1) | WO2010015335A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103476405A (zh) * | 2011-02-07 | 2013-12-25 | 持田制药株式会社 | 舒张性充血性心力衰竭治疗剂 |
RU2014130779A (ru) * | 2011-12-27 | 2016-02-20 | Конинклейке Филипс Н.В. | Способ и система для сокращения ранней повторной госпитализации |
EP3906920A1 (en) * | 2014-06-06 | 2021-11-10 | Marine Ingredients, LLC | Omega-3 compositions, dosage forms, and methods of use |
WO2019022436A2 (ko) * | 2017-07-27 | 2019-01-31 | 에리슨제약(주) | Nep 저해제 및 베타-차단제를 포함하는 약제학적 조성물 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2218984B (en) | 1988-05-27 | 1992-09-23 | Renafield Limited | Process for preparing high-concentration mixtures of polyunsaturated fatty acids & their esters and their prophylactic or therapeutic uses |
GB8819110D0 (en) | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
CN1082909A (zh) | 1993-01-03 | 1994-03-02 | 潘玉珍 | 精制二十二碳六烯酸乙酯复合溶栓、抗痴呆药剂 |
US5760081A (en) | 1994-05-10 | 1998-06-02 | The General Hospital Corporation | Omega 3 fatty acids in the prevention of ventricular fibrillation |
US5541225A (en) * | 1994-10-11 | 1996-07-30 | The General Hospital Corporation | α-Linolenic acid and eicosatetraynoic acid in the prevention and treatment of ventricular tachyarrhythmia |
IT1277953B1 (it) | 1995-12-21 | 1997-11-12 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per |
IT1308613B1 (it) * | 1999-02-17 | 2002-01-09 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella prevenzione di eventi cardiovascolari. |
ITMI20010129A1 (it) | 2001-01-25 | 2002-07-25 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco |
ITMI20012384A1 (it) | 2001-11-12 | 2003-05-12 | Quatex Nv | Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori |
US20060135610A1 (en) * | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Cardiovascular compositions |
KR20090086078A (ko) * | 2006-10-13 | 2009-08-10 | 릴라이언트 파마슈티컬스 인코퍼레이티드 | 항부정맥제 및 오메가-3 지방산 및 이들의 조합 생성물로의 치료 |
-
2009
- 2009-07-23 RS RS20140649A patent/RS53694B1/en unknown
- 2009-07-23 EA EA201100143A patent/EA020237B1/ru not_active IP Right Cessation
- 2009-07-23 US US13/057,492 patent/US8592439B2/en active Active
- 2009-07-23 SI SI200931073T patent/SI2323647T1/sl unknown
- 2009-07-23 EP EP09777388.1A patent/EP2323647B1/en active Active
- 2009-07-23 WO PCT/EP2009/005347 patent/WO2010015335A1/en active Application Filing
- 2009-07-23 ES ES09777388.1T patent/ES2524596T3/es active Active
- 2009-07-23 CA CA2732071A patent/CA2732071C/en active Active
- 2009-07-23 BR BRPI0917403A patent/BRPI0917403A2/pt not_active IP Right Cessation
- 2009-07-23 KR KR1020117002755A patent/KR20110058775A/ko active Search and Examination
- 2009-07-23 CN CN2009801356010A patent/CN102149376B/zh active Active
- 2009-07-23 PL PL09777388T patent/PL2323647T3/pl unknown
- 2009-07-23 JP JP2011521456A patent/JP5563573B2/ja not_active Expired - Fee Related
- 2009-07-23 PT PT97773881T patent/PT2323647E/pt unknown
- 2009-07-23 DK DK09777388.1T patent/DK2323647T3/en active
- 2009-07-23 AU AU2009278317A patent/AU2009278317B2/en not_active Ceased
- 2009-07-23 MX MX2011001419A patent/MX2011001419A/es active IP Right Grant
-
2012
- 2012-02-09 HK HK12101284.9A patent/HK1160790A1/zh not_active IP Right Cessation
-
2014
- 2014-11-25 HR HRP20141149AT patent/HRP20141149T1/hr unknown
- 2014-11-26 CY CY20141100980T patent/CY1115785T1/el unknown
-
2015
- 2015-01-21 SM SM201500019T patent/SMT201500019B/xx unknown
Non-Patent Citations (5)
Title |
---|
David J.A. Jenkins et al..Heterogeneity in Randomized Controlled Trials of Long Chain (Fish) Omega-3 Fatty Acids in Restenosis,Secondary Prevention and Ventricular Arrhythmias.《Journal of the American College of Nutrition》.2008,第27卷(第3期),第367–378页. * |
DavidJ.A.Jenkinsetal..HeterogeneityinRandomizedControlledTrialsofLongChain(Fish)Omega-3FattyAcidsinRestenosis Secondary Prevention and Ventricular Arrhythmias.《Journal of the American College of Nutrition》.2008 |
Luigi Tavazzi et al..Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.《The European Journal of Heart Failure》.2004,第6卷第635– 641页. * |
Marchioli et al..Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.《the lancet》.1999,第354卷第447-455页. * |
R. Marchioli et al..Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations.《European Heart Journal》.2001,第22卷(第22期),第2085–2103页. * |
Also Published As
Publication number | Publication date |
---|---|
RS53694B1 (en) | 2015-04-30 |
HK1160790A1 (zh) | 2012-08-17 |
SMT201500019B (it) | 2015-03-05 |
WO2010015335A8 (en) | 2010-04-29 |
CY1115785T1 (el) | 2017-01-25 |
AU2009278317A1 (en) | 2010-02-11 |
EA201100143A1 (ru) | 2011-10-31 |
BRPI0917403A2 (pt) | 2015-12-01 |
JP5563573B2 (ja) | 2014-07-30 |
AU2009278317B2 (en) | 2014-12-18 |
WO2010015335A1 (en) | 2010-02-11 |
EP2323647B1 (en) | 2014-09-10 |
MX2011001419A (es) | 2011-05-25 |
EP2323647A1 (en) | 2011-05-25 |
EA020237B1 (ru) | 2014-09-30 |
JP2011529928A (ja) | 2011-12-15 |
DK2323647T3 (en) | 2014-12-08 |
CA2732071A1 (en) | 2010-02-11 |
HRP20141149T1 (hr) | 2015-02-13 |
US8592439B2 (en) | 2013-11-26 |
CN102149376A (zh) | 2011-08-10 |
AU2009278317A8 (en) | 2011-03-31 |
CA2732071C (en) | 2018-02-13 |
US20110178111A1 (en) | 2011-07-21 |
PT2323647E (pt) | 2014-12-16 |
SI2323647T1 (sl) | 2015-01-30 |
PL2323647T3 (pl) | 2015-03-31 |
KR20110058775A (ko) | 2011-06-01 |
ES2524596T3 (es) | 2014-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220175709A1 (en) | Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same | |
US20200108041A1 (en) | Methods of reducing ldl-p | |
AU2014202449B2 (en) | Compositions and methods for lowering triglycerides without raising ldl-c levels | |
EP2800469B1 (en) | Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject | |
JP2021001193A (ja) | 重水素化又は非重水素化分子及び医薬製剤 | |
JP2010506920A (ja) | Lp−pla2濃度を減少させるためのオメガ−3脂肪酸 | |
US20070135521A1 (en) | Agent for Preventing Metabolic Syndrome | |
CN102149376B (zh) | 症状性心力衰竭的长期治疗 | |
JP2020523408A (ja) | 2型糖尿病の患者における心血管イベントの低減又は予防方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1160790 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: SIGMA TAU PHARMACEUTICALS INC. Free format text: FORMER OWNER: SIKESITE MEDICINE COMPANY Effective date: 20121015 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20121015 Address after: Milan Italy Applicant after: Prodotti Antibiotici SPA Applicant after: Sigma-Tau Industrie Farmaceutiche Riunite S. P. A. Address before: Milan Italy Applicant before: Prodotti Antibiotici SPA Applicant before: Sixterpharma S. R. L. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1160790 Country of ref document: HK |